Table 1 Baseline characteristics of all patients diagnosed with PCV including those that were later excluded due to lost to follow up

No. of eyes (%)

59 (55.6%)

47 (44.3%)

–

106

No. bilateral (%)

9 (15.3%)

4 (8.5%)

–

13 (12.3%)

Mean age (SD), years

76.0 (9.7)

67.3 (9.1)

0.002^d

72.1 (10.3)

Gender, male (%)

19 (32.2%)

23 (48.9%)

0.11^c

42 (39.6%)

Mean baseline VA (SD), letters

63.3 (15.5)

53.1 (21.5)

0.008^e

58.8 (19.0)

VA ≥70 letters (20/40 Snellen)

23 (38.9%)

11 (23.4%)

0.098^c

34 (32.1%)

VA ≤ 35 letters (20/200 Snellen equivalent)

4 (6.8%)

9 (19.1%)

0.074^c

13 (12.3%)

Presence of CVH, no (%)

8 (25.8%)

17 (50.0%)

0.013^c

25 (34.2%)

Pachychoroid phenotype, no (%)

29 (60.4%)

30 (73.2%)

0.262^c

59 (66.3%)

Presence of BVN, no (%)

25 (42.4%)

31 (66.0%)

0.019^c

56 (52.8%)

Foveal involvement, no. (%)

32 (54.2%)

38 (80.9%)

0.007^c

70 (66.0%)

Cluster/String Configuration, no. (%)

29 (49.2%)

32 (68.1%)

0.075^c

61 (57.5%)

Solitary polyp Configuration, no. (%)

16 (27.1%)

7 (14.9%)

0.158^c

23 (21.7%)

Early filling^a, no. (%)

8 (13.6%)

18 (38.3%)

0.006^c

26 (24.5%)

Late filling^b, no. (%)

30 (50.8%)

18 (38.3%)

0.240^c

48 (45.3%)

Mean (SD) Central Retinal Thickness, microns

384 (160)

423 (251)

0.839^e

400 (204)

Mean GLD (SD), microns

2750 (1600)

4018 (1904)

0.013^e

3452 (1870)